Your browser doesn't support javascript.
loading
Prevalence of the apolipoprotein E ε4 allele in amyloid ß positive subjects across the spectrum of Alzheimer's disease.
Mattsson, Niklas; Groot, Colin; Jansen, Willemijn J; Landau, Susan M; Villemagne, Victor L; Engelborghs, Sebastiaan; Mintun, Mark M; Lleo, Alberto; Molinuevo, José Luis; Jagust, William J; Frisoni, Giovanni B; Ivanoiu, Adrian; Chételat, Gaël; Resende de Oliveira, Catarina; Rodrigue, Karen M; Kornhuber, Johannes; Wallin, Anders; Klimkowicz-Mrowiec, Aleksandra; Kandimalla, Ramesh; Popp, Julius; Aalten, Pauline P; Aarsland, Dag; Alcolea, Daniel; Almdahl, Ina S; Baldeiras, Inês; van Buchem, Mark A; Cavedo, Enrica; Chen, Kewei; Cohen, Ann D; Förster, Stefan; Fortea, Juan; Frederiksen, Kristian S; Freund-Levi, Yvonne; Gill, Kiran Dip; Gkatzima, Olymbia; Grimmer, Timo; Hampel, Harald; Herukka, Sanna-Kaisa; Johannsen, Peter; van Laere, Koen; de Leon, Mony J; Maier, Wolfgang; Marcusson, Jan; Meulenbroek, Olga; Møllergård, Hanne M; Morris, John C; Mroczko, Barbara; Nordlund, Arto; Prabhakar, Sudesh; Peters, Oliver.
Afiliación
  • Mattsson N; Clinical Memory Research Unit, Clinical Sciences Malmö, Lund University, Lund, Sweden. Electronic address: niklas.mattsson@med.lu.se.
  • Groot C; Department of Neurology and Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands.
  • Jansen WJ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands.
  • Landau SM; Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA.
  • Villemagne VL; Department of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia.
  • Engelborghs S; Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium.
  • Mintun MM; Avid Radiopharmaceuticals, Philadelphia, PA, USA.
  • Lleo A; Neurology Department, Hospital de Sant Pau, Barcelona, Spain.
  • Molinuevo JL; Alzheimer's Disease and Other Cognitive Disorders Unit, IDIBAPS, Clinic University Hospital, Barcelona, Spain.
  • Jagust WJ; Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA.
  • Frisoni GB; Memory Clinic and LANVIE- Laboratory of Neuroimaging of Aging, University Hospitals, and University of Geneva, Geneva, Switzerland; Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Ivanoiu A; Memory Clinic and Neurochemistry Laboratory, Saint Luc University Hospital, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium.
  • Chételat G; Inserm, Inserm UMR-S U1237, Université de Caen-Normandie, GIP Cyceron, Caen, France.
  • Resende de Oliveira C; Center for Neuroscience and Cell Biology, Faculty of Medicine, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
  • Rodrigue KM; Center for Vital Longevity, School of Behavioral and Brain Sciences, The University of Texas at Dallas, Dallas, TX, USA.
  • Kornhuber J; Department of Psychiatry and Psychotherapy, Friedrich-Alexander University of Erlangen- Nuremberg, Erlangen, Germany.
  • Wallin A; Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
  • Klimkowicz-Mrowiec A; Jagiellonian University College of Medicine, Krakow, Poland.
  • Kandimalla R; Department of Biochemistry, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Popp J; Department of Psychiatry, Service of Old Age Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.
  • Aalten PP; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands.
  • Aarsland D; Center for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Alcolea D; Neurology Department, Hospital de Sant Pau, Barcelona, Spain.
  • Almdahl IS; Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
  • Baldeiras I; Center for Neuroscience and Cell Biology, Faculty of Medicine, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
  • van Buchem MA; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Cavedo E; Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Dé
  • Chen K; Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Cohen AD; University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, PA, USA.
  • Förster S; Department of Nuclear Medicine, Technische Universitaet München, Munich, Germany.
  • Fortea J; Neurology Department, Hospital de Sant Pau, Barcelona, Spain.
  • Frederiksen KS; Danish Dementia Research Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Freund-Levi Y; Department of Geriatrics, Karolinska University Hospital Huddinge, Section of Clinical Geriatrics, Institution of NVS, Karolinska Institutet, Stockholm, Sweden.
  • Gill KD; Department of Biochemistry, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Gkatzima O; Third Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Grimmer T; Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitaet München, Munich, Germany.
  • Hampel H; AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Paris, Franc
  • Herukka SK; Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
  • Johannsen P; Memory Clinic, Danish Dementia Research Center, Rigshospitalet, Copenhagen, Denmark.
  • van Laere K; Department of Imaging and Pathology, Catholic University Leuven, Leuven, Belgium.
  • de Leon MJ; School of Medicine, Center for Brain Health, New York University, New York, NY, USA.
  • Maier W; Department of Psychiatry and Psychotherapy, University of Bonn, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Marcusson J; Geriatric Medicine, Department of Clinical and Experimental Medicine, University of Linköping, Linköping, Sweden.
  • Meulenbroek O; Department of Geriatric Medicine, Radboud Alzheimer Center, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Møllergård HM; Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
  • Morris JC; Knight Alzheimer's Disease Research Center, Department of Neurology, Washington University School of Medicine, St Louis, MO, USA.
  • Mroczko B; Department of Neurodegeneration Diagnostics, Leading National Research Centre in Bialystok (KNOW), Medical University of Bialystok, Bialystok, Poland.
  • Nordlund A; Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
  • Prabhakar S; Department of Neurology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Peters O; Department of Psychiatry and Psychotherapy, Charité Berlin, German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Alzheimers Dement ; 14(7): 913-924, 2018 07.
Article en En | MEDLINE | ID: mdl-29601787
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos beta-Amiloides / Apolipoproteína E4 / Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Alzheimers Dement Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos beta-Amiloides / Apolipoproteína E4 / Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Alzheimers Dement Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos